Cargando…

Early Outcomes and Complications of Synthetic Cartilage Implant for Treatment of Hallux Rigidus in the United States

CATEGORY: Midfoot/Forefoot INTRODUCTION/PURPOSE: The aim of this study was to determine the outcomes and early complications following the implantation of a novel hydrogel synthetic cartilage implant (SCI) for the treatment of hallux rigidus by a single surgeon. This implant was FDA approved for imp...

Descripción completa

Detalles Bibliográficos
Autores principales: Cassinelli, Spenser J., Chen, Stephanie, Charlton, Timothy P., Thordarson, David B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8696832/
http://dx.doi.org/10.1177/2473011419S00132
_version_ 1784619906053963776
author Cassinelli, Spenser J.
Chen, Stephanie
Charlton, Timothy P.
Thordarson, David B.
author_facet Cassinelli, Spenser J.
Chen, Stephanie
Charlton, Timothy P.
Thordarson, David B.
author_sort Cassinelli, Spenser J.
collection PubMed
description CATEGORY: Midfoot/Forefoot INTRODUCTION/PURPOSE: The aim of this study was to determine the outcomes and early complications following the implantation of a novel hydrogel synthetic cartilage implant (SCI) for the treatment of hallux rigidus by a single surgeon. This implant was FDA approved for implantation for the treatment of hallux rigidus in the United States in July 2016. METHODS: A retrospective chart review of consecutive patients who underwent treatment for hallux rigidus with an SCI between August 2016 and June 2018 by a single surgeon was performed. Demographic information, radiographic assessment, and concomitant surgical procedures performed were evaluated for all patients. Post operatively, PROMIS physical function and pain scores, patient satisfaction, reoperation, conversion to arthrodesis, and need for further clinical treatment were collected. Seventy SCI were implanted in 65 patients. Follow up averaged 16.3 months (Range 6-27 months). RESULTS: 16% (11/67) of patients were very satisfied, 31% (21/67) were satisfied, 22% (15/67) were neutral, 6% (4/67) were dissatisfied, and 24% (16/67) were very dissatisfied with their outcome. PROMIS physical function scores averaged 43, indicating mild dysfunction compared to population norms. PROMIS pain interference scores averaged 59, indicating mild pain compared to population norms. 50% (35/70) required a corticosteroid injection post-operatively. 24% (17/70) required advanced imaging with MRI post-operatively. There was a 13% reoperation rate for all-cause reoperation, and a 2.9% rate of conversion to arthrodesis. Subgroup analysis showed that patients undergoing Moberg osteotomy at time of SCI performed better than patients undergoing SCI alone. CONCLUSION: Synthetic cartilage implantation yielded modest patient satisfaction, mild dysfunction in physical measures, and a large proportion requiring further treatment and workup post operatively. We believe patient selection and counseling on the potential for continued pain and dysfunction in the early postoperative period following this procedure are important before proceeding with synthetic cartilage implantation for hallux rigidus.
format Online
Article
Text
id pubmed-8696832
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-86968322022-01-28 Early Outcomes and Complications of Synthetic Cartilage Implant for Treatment of Hallux Rigidus in the United States Cassinelli, Spenser J. Chen, Stephanie Charlton, Timothy P. Thordarson, David B. Foot Ankle Orthop Article CATEGORY: Midfoot/Forefoot INTRODUCTION/PURPOSE: The aim of this study was to determine the outcomes and early complications following the implantation of a novel hydrogel synthetic cartilage implant (SCI) for the treatment of hallux rigidus by a single surgeon. This implant was FDA approved for implantation for the treatment of hallux rigidus in the United States in July 2016. METHODS: A retrospective chart review of consecutive patients who underwent treatment for hallux rigidus with an SCI between August 2016 and June 2018 by a single surgeon was performed. Demographic information, radiographic assessment, and concomitant surgical procedures performed were evaluated for all patients. Post operatively, PROMIS physical function and pain scores, patient satisfaction, reoperation, conversion to arthrodesis, and need for further clinical treatment were collected. Seventy SCI were implanted in 65 patients. Follow up averaged 16.3 months (Range 6-27 months). RESULTS: 16% (11/67) of patients were very satisfied, 31% (21/67) were satisfied, 22% (15/67) were neutral, 6% (4/67) were dissatisfied, and 24% (16/67) were very dissatisfied with their outcome. PROMIS physical function scores averaged 43, indicating mild dysfunction compared to population norms. PROMIS pain interference scores averaged 59, indicating mild pain compared to population norms. 50% (35/70) required a corticosteroid injection post-operatively. 24% (17/70) required advanced imaging with MRI post-operatively. There was a 13% reoperation rate for all-cause reoperation, and a 2.9% rate of conversion to arthrodesis. Subgroup analysis showed that patients undergoing Moberg osteotomy at time of SCI performed better than patients undergoing SCI alone. CONCLUSION: Synthetic cartilage implantation yielded modest patient satisfaction, mild dysfunction in physical measures, and a large proportion requiring further treatment and workup post operatively. We believe patient selection and counseling on the potential for continued pain and dysfunction in the early postoperative period following this procedure are important before proceeding with synthetic cartilage implantation for hallux rigidus. SAGE Publications 2019-10-28 /pmc/articles/PMC8696832/ http://dx.doi.org/10.1177/2473011419S00132 Text en © The Author(s) 2019 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Article
Cassinelli, Spenser J.
Chen, Stephanie
Charlton, Timothy P.
Thordarson, David B.
Early Outcomes and Complications of Synthetic Cartilage Implant for Treatment of Hallux Rigidus in the United States
title Early Outcomes and Complications of Synthetic Cartilage Implant for Treatment of Hallux Rigidus in the United States
title_full Early Outcomes and Complications of Synthetic Cartilage Implant for Treatment of Hallux Rigidus in the United States
title_fullStr Early Outcomes and Complications of Synthetic Cartilage Implant for Treatment of Hallux Rigidus in the United States
title_full_unstemmed Early Outcomes and Complications of Synthetic Cartilage Implant for Treatment of Hallux Rigidus in the United States
title_short Early Outcomes and Complications of Synthetic Cartilage Implant for Treatment of Hallux Rigidus in the United States
title_sort early outcomes and complications of synthetic cartilage implant for treatment of hallux rigidus in the united states
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8696832/
http://dx.doi.org/10.1177/2473011419S00132
work_keys_str_mv AT cassinellispenserj earlyoutcomesandcomplicationsofsyntheticcartilageimplantfortreatmentofhalluxrigidusintheunitedstates
AT chenstephanie earlyoutcomesandcomplicationsofsyntheticcartilageimplantfortreatmentofhalluxrigidusintheunitedstates
AT charltontimothyp earlyoutcomesandcomplicationsofsyntheticcartilageimplantfortreatmentofhalluxrigidusintheunitedstates
AT thordarsondavidb earlyoutcomesandcomplicationsofsyntheticcartilageimplantfortreatmentofhalluxrigidusintheunitedstates